155 related articles for article (PubMed ID: 131369)
1. Uremia as a state of immune deficiency.
Birkeland SA
Scand J Immunol; 1976; 5(1-2):107-15. PubMed ID: 131369
[TBL] [Abstract][Full Text] [Related]
2. Immune deficiency of the uremic patient.
Chatenoud L; Herbelin A; Beaurain G; Descamps-Latscha B
Adv Nephrol Necker Hosp; 1990; 19():259-74. PubMed ID: 2105582
[No Abstract] [Full Text] [Related]
3. Derangement of humoral immune system in nondialyzed uremic patients.
Kamata K; Okubo M
Jpn J Med; 1984 Feb; 23(1):9-15. PubMed ID: 6379244
[TBL] [Abstract][Full Text] [Related]
4. Lymphocytes from multitransfused uremic patients have poor MLC reactivity.
Fehrman I; Ringdén O
Tissue Antigens; 1981; 17(4):386-95. PubMed ID: 6460343
[TBL] [Abstract][Full Text] [Related]
5. In vitro reactivity of lymphocytes obtained from uraemic patients maintained by heamodialysis.
Sengar DP; Rashid A; Harris JE
Clin Exp Immunol; 1975 Aug; 21(2):298-305. PubMed ID: 126831
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte proliferation in uremic patients: correlation with zinc status.
Shu KH; Lu YS; Chen CH; Chen DC; Lee SH; Lian JD
J Formos Med Assoc; 1993 Nov; 92(11):1017-20. PubMed ID: 7910061
[TBL] [Abstract][Full Text] [Related]
7. Immunological studies in uremic and kidney transplanted patients.
Langhoff E
Dan Med Bull; 1989 Apr; 36(2):160-75. PubMed ID: 2651030
[TBL] [Abstract][Full Text] [Related]
8. Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect.
Kurz P; Köhler H; Meuer S; Hütteroth T; Meyer zum Büschenfelde KH
Kidney Int; 1986 Jun; 29(6):1209-14. PubMed ID: 3489122
[TBL] [Abstract][Full Text] [Related]
9. An immunosuppressive factor(s) in uremic sera.
Kamata K; Okubo M; Marumo F
Proc Clin Dial Transplant Forum; 1980; 10():47-50. PubMed ID: 6981113
[No Abstract] [Full Text] [Related]
10. Effect of interleukin-2 and methylprednisolone on in vitro transformation of uremic lymphocytes.
Langhoff E; Ladefoged J; Odum N
Int Arch Allergy Appl Immunol; 1986; 81(1):5-11. PubMed ID: 3488966
[TBL] [Abstract][Full Text] [Related]
11. Humoral inhibitors of the immune response in uremia. II. Further characterization of an immunosuppressive factor in uremic serum.
Raskova J; Morrison AB; Shea SM; Raska K
Am J Pathol; 1979 Nov; 97(2):277-90. PubMed ID: 230740
[TBL] [Abstract][Full Text] [Related]
12. Humoral inhibitors of the immune response in uremia. I. Effect of serum and of the supernatant of spleen cultures from uremic rats on the mixed lymphocyte reaction.
Raskova J; Morrison AB
Lab Invest; 1978 Jan; 38(1):103-9. PubMed ID: 146111
[TBL] [Abstract][Full Text] [Related]
13. Analysis of humoral and cellular factors that contribute to impaired immune responsiveness in experimental uremia.
Mezzano S; Pesce AJ; Pollak VE; Michael JG
Nephron; 1984; 36(1):15-9. PubMed ID: 6606788
[TBL] [Abstract][Full Text] [Related]
14. MLC-blocking factors in uremic sera.
Fehrman I; Ringdén O; Bergström J
Clin Nephrol; 1980 Oct; 14(4):183-9. PubMed ID: 7000408
[TBL] [Abstract][Full Text] [Related]
15. Proliferation in autologous mixed lymphocyte reactions, expression of HLA-class II antigen and serum immunomodulatory activity in patients with renal insufficiency on chronic dialysis.
Puppo F; Gurreri G; Pattarini R; Ranise A; Indiveri F
Allergol Immunopathol (Madr); 1991; 19(4):167-73. PubMed ID: 1840170
[TBL] [Abstract][Full Text] [Related]
16. Defective radioresistant suppressor cell activity in hemodialysis patients.
Mirapeix E; Montoliu J; Suárez C; López Pedret J; Revert L
Nephron; 1985; 41(2):184-8. PubMed ID: 2931611
[TBL] [Abstract][Full Text] [Related]
17. In vitro characterization of immunological responsiveness of uremic patients.
Kunori T; Fehrman I; Ringdén O; Möller E
Nephron; 1980; 26(5):234-9. PubMed ID: 6448353
[TBL] [Abstract][Full Text] [Related]
18. The effect of maintenance dialysis on lymphocyte function. I. Haemodialysis.
Holdsworth SR; Fitzgerald MG; Hosking CS; Atkins RC
Clin Exp Immunol; 1978 Jul; 33(1):95-101. PubMed ID: 709914
[TBL] [Abstract][Full Text] [Related]
19. Modification of some lymphocyte functions in vitro by opioid receptor agonists and antagonist in chronic uremic patients and healthy subjects.
Zbróg Z; Luciak M; Tchórzewski H; Pokoca L
Int J Immunopharmacol; 1991; 13(5):475-83. PubMed ID: 1664419
[TBL] [Abstract][Full Text] [Related]
20. In vitro cellular immunity and in vivo delayed hypersensitivity in uremic patients maintained on hemodialysis.
Sengar DP; Rashid A; Harris JE
Int Arch Allergy Appl Immunol; 1974; 47(6):829-38. PubMed ID: 4279227
[No Abstract] [Full Text] [Related]
[Next] [New Search]
